参考文献/References:
[1]王励,黄瑞英.肝硬化患者凝血功能检测临床价值分析[J].医学信息,2015,28(46):26.
[2]刘君.肝硬化患者凝血酶原时间和血小板的检验价值分析[J].中国医药指南,2013,20(13):219-220.
[3]林壮琼,张展青.肝硬化患者凝血功能和血小板检测分析[J].检验医学与临床,2013,10(8):986-987.
[4]张宝忠,王春红,蒋福国,等.乙肝肝硬化患者凝血四项与血小板指标变化的分析探讨[J].医学信息,2014,27(12):554.
[5]侯会香.肝硬化患者凝血酶原时间与血小板检验的临床价值[J].临床合理用药杂志,2015,8(26):86-87.
[6]张雪松,张晓燕.肝硬化患者凝血酶原时间和血小板参数检测分析[J].检验医学与临床,2011,08(20):2518-2519.
相似文献/References:
[1]王 霞,周 华.血清胱抑素C、凝血功能检测在急性脑梗死患者中的应用价值[J].医学信息,2022,35(22):148.[doi:10.3969/j.issn.1006-1959.2022.22.036]
WANG Xia,ZHOU Hua.Application Value of Detection of Serum Cystatin C and Coagulation Function in Patients with Acute Cerebral Infarction[J].Journal of Medical Information,2022,35(04):148.[doi:10.3969/j.issn.1006-1959.2022.22.036]
[2]王 杰.阿加曲班对脑梗塞急性期患者血液流变指标及APTT、PT的影响[J].医学信息,2022,35(22):130.[doi:10.3969/j.issn.1006-1959.2022.22.030]
WANG Jie.Effects of Argatroban on Hemorheology Indexes, APTT and PT in Patients with Acute Cerebral Infarction[J].Journal of Medical Information,2022,35(04):130.[doi:10.3969/j.issn.1006-1959.2022.22.030]
[3]刘立楠.肝硬化患者上消化道出血危险因素与预后影响因素分析[J].医学信息,2021,34(14):3.[doi:10.3969/j.issn.1006-1959.2021.14.002]
LIU Li-nan.Analysis of Risk Factors and Prognostic Factors of Upper Gastrointestinal Bleeding in Patients with Liver Cirrhosis[J].Journal of Medical Information,2021,34(04):3.[doi:10.3969/j.issn.1006-1959.2021.14.002]
[4]龙颖婷,龙成学.凝血检验指标在弥漫性血管内凝血诊断中的应用[J].医学信息,2024,37(13):142.[doi:10.3969/j.issn.1006-1959.2024.13.030]
Application of Coagulation Test Indexes in the Diagnosis of Disseminated Intravascular Coagulation.Application of Coagulation Test Indexes in the Diagnosis of Disseminated Intravascular Coagulation[J].Journal of Medical Information,2024,37(04):142.[doi:10.3969/j.issn.1006-1959.2024.13.030]